公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size | ZHONG-ZHE LIN ; Shau W.-Y.; CHIUN HSU ; YU-YUN SHAO ; Yeh Y.-C.; Kuo R.N.-C.; CHIH-HUNG HSU ; CHIH-HSIN YANG ; ANN-LII CHENG ; Lai M.-S. | PLoS ONE | 26 | 24 | |
2008 | Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response | Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG ; Chiu Y.-H.; SUNG-HSIN KUO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Clinical Cancer Research | 132 | 125 | |
2017 | Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) | Nokihara H; Lu S; Mok T.S.K; Nakagawa K; Yamamoto N; Shi Y.K; Zhang L; Soo R.A; CHIH-HSIN YANG ; Sugawara S; Nishio M; Takahashi T; Goto K; Chang J; Maemondo M; Ichinose Y; Cheng Y; Lim W.T; Morita S; Tamura T. | Annals of Oncology | 74 | 68 | |
2016 | A randomized phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in asian patients with advanced stage pulmonary adenocarcinoma | Mok T.S.K; Geater S.L; Su W.-C; Tan E.-H; CHIH-HSIN YANG ; Chang G.-C; Han M; Komarnitsky P; Payumo F; Garrus J.E; Close S; Park K. | Journal of Thoracic Oncology | 44 | 41 | |
2020 | A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis | CHIH-HSIN YANG ; Cheng Y.; Murakami H.; PAN-CHYR YANG ; He J.; Nakagawa K.; Kang J.H.; Kim J.-H.; Hozak R.R.; Nguyen T.S.; Zhang W.L.; Enatsu S.; Puri T.; Orlando M. | Journal of Thoracic Oncology | 29 | 28 | |
2012 | Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer | Ahn M.-J; CHIH-HSIN YANG ; Liang J; Kang J.-H; Xiu Q; Chen Y.-M; Blair J.M; Peng G; Linn C; Orlando M. | Lung Cancer | 22 | 21 | |
2016 | Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations | Cheng Y.; Murakami H; PAN-CHYR YANG ; He J; Nakagawa K; Kang J.H; Kim J.-H; Wang X; Enatsu S; Puri T; Orlando M; CHIH-HSIN YANG | Journal of Clinical Oncology | 160 | 134 | |
2023 | Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis | Liam, Chong Kin; Ahmad, Azura Rozila; Hsia, Te-Chun; Zhou, Jianying; Kim, Dong-Wan; Soo, Ross Andrew; Cheng, Ying; Lu, Shun; Shin, Sang Won; CHIH-HSIN YANG ; Zhang, Yiping; Zhao, Jun; Berghoff, Karin; Bruns, Rolf; Johne, Andreas; Wu, Yi-Long | Clinical cancer research : an official journal of the American Association for Cancer Research | 8 | 4 | |
2017 | A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician's choice in patients with advanced non-small cell lung cancer | Katakami N; Felip E; Spigel D.R; Kim J.-H; Olivo M; Guo M; Nokihara H; CHIH-HSIN YANG ; Iannotti N; Satouchi M; Barlesi F. | Annals of Oncology | 14 | 11 | |
2015 | Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene | Wu H.; JIN-YUAN SHIH ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 15 | 14 | |
2022 | Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib | CHIH-HSIN YANG ; Brose, Marcia S; Castro, Gilberto; Kim, Edward S; Lassen, Ulrik N; Leyvraz, Serge; Pappo, Alberto; López-Ríos, Fernando; Reeves, John A; Fellous, Marc; Penault-Llorca, Frédérique; Rudzinski, Erin R; Tabatabai, Ghazaleh; Vassal, Gilles; Drilon, Alexander; Trent, Jonathan | BMC cancer | 6 | 5 | |
2024 | Re-inventing a better wheel? Serplulimab for squamous cell lung cancer | DE-RUI HUANG ; CHIH-HSIN YANG | Cancer cell | | | |
2017 | Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; Chia-Chi Lin ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 25 | 25 | |
2021 | Real-world insights into patients with advanced NSCLC and MET alterations | Bittoni M.; CHIH-HSIN YANG ; JIN-YUAN SHIH ; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K. | Lung Cancer | 11 | 9 | |
2018 | Real-World or Controlled Clinical Trial Data in Real-World Practice | Wu T.-H; CHIH-HSIN YANG | Journal of Thoracic Oncology | 2 | 1 | |
2022 | Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma | CHIA-LING CHANG ; MIN-SHU HSIEH ; JIN-YUAN SHIH ; Lee, Yi-Hsuan; WEI-YU LIAO ; CHIA-LIN HSU ; CHING-YAO YANG ; KUAN-YU CHEN ; JIH-HSIANG LEE ; CHAO-CHI HO ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; CHONG-JEN YU | Therapeutic advances in medical oncology | 1 | 1 | |
2023 | Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice | Fong, Chin Heng; Meti, Nicholas; Kruser, Timothy; Weiss, Jessica; Liu, Zhihui Amy; Takami, Hirokazu; Narita, Yoshitaka; de Moraes, Fabio Ynoe; Dasgupta, Archya; Ong, Choo Khoon; CHIH-HSIN YANG ; JIH-HSIANG LEE ; Kosyak, Natalya; Pavlakis, Nicholas; Kongkham, Paul; Doherty, Mark; Leighl, Natasha B; Shultz, David B | Journal of thoracic disease | 3 | 3 | |
2022 | Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice | Jablonska, Paola Anna; Fong, Chin Heng; Kruser, Timothy; Weiss, Jessica; Liu, Zhihui Amy; Takami, Hirokazu; Narita, Yoshitaka; Ynoe de Moraes, Fabio; Dasgupta, Archya; Ong, Choo Khoon; CHIH-HSIN YANG ; JIH-HSIANG LEE ; Pavlakis, Nicholas; Kongkham, Paul; Butler, Marcus; Shultz, David B | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2 | 2 | |
2017 | Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al | CHIH-HSIN YANG ; Puri T; Orlando M; Cheng Y. | Journal of Clinical Oncology | 0 | 0 | |
2014 | Reply to E.R. Haspinger et al | CHIH-HSIN YANG ; Sequist L.V. | Journal of Clinical Oncology | 0 | 0 | |